Clark Eliana sold NTLA
July 1, 2025 · Form 4 insider transaction
Clark Eliana sold 1,022 shares of Intellia Therapeutics, Inc. at $9.82 per share, a transaction worth $10.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,022
Price
$9.82
Total value
$10.0K
InsiderClark Eliana
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 1, 2025
Filing dateJuly 3, 2025
Shares owned after95,369
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Sale of 1,022 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2025.